Progesterone antagonists block the growth of experimental mammary tumors in G0/G1
- 1 December 1990
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 17 (2), 155-156
- https://doi.org/10.1007/bf01806296
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell deathJournal of Steroid Biochemistry, 1989
- Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: Mechanistic studiesBreast Cancer Research and Treatment, 1989
- ANTIPROGESTINS, A NEW FORM OF ENDOCRINE THERAPY FOR HUMAN-BREAST CANCER1989
- Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the ratEuropean Journal of Cancer and Clinical Oncology, 1989
- EFFECT ON GROWTH AND CELL-CYCLE KINETICS OF ESTRADIOL AND TAMOXIFEN ON MCF-7 HUMAN-BREAST CANCER-CELLS GROWN-INVITRO AND IN NUDE-MICE1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- EVALUATION OF A MODELING SYSTEM FOR S-PHASE ESTIMATION IN BREAST-CANCER BY FLOW-CYTOMETRY1987
- Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.1985
- Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.The Journal of cell biology, 1982
- NEOPLASTIC TRANSFORMATION AND DEFECTIVE CONTROL OF CELL-PROLIFERATION AND DIFFERENTIATION1982